Evidence map›Paper›PMID 32476825›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2017

Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT.

Alicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, Fleur Cohen-Aubart, Laurent Pérard, Laurence Bouillet, Sébastien Abad, Philip Bielefeld, Diane Bouvry, Marc André and 13 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Choroidal Nodules in Ocular Sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023
    Article
  3. Sarcoid Uveitis: An Intriguing Challenger.Medicina (Kaunas, Lithuania) · 2022
    Review
  4. Article
  5. Refractory Sarcoidosis: A Review.Therapeutics and clinical risk management · 2020
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 1 institution in 1 country.

Alicia MarquetDépartement de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, F-69004, Lyon, France.
Catherine Chapelon-AbricDépartement de Médecine Interne et d'Immunologie Clinique II, Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Pitié Salpêtrière, Université Pierre et Marie Curie (UPMC), F-75006, Paris, France.
Delphine Maucort-BoulchService de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France.
Fleur Cohen-AubartDépartement de Médecine Interne et d'Immunologie Clinique, AP-HP, CHU Pitié Salpêtrière, Institut E3M, Université Pierre et Marie Curie, F-75006, Paris, France.
Laurent PérardUniversité Claude Bernard, Lyon 1, F-69100, Villeurbanne, France.
Laurence BouilletDépartement de Médecine Interne, Centre Hospitalier Universitaire, F-38700, Grenoble, France.
Sébastien AbadDépartement de Médecine Interne, Hôpital Avicenne, Université Paris 13, F-93000, Bobigny, France.
Philip BielefeldDépartement de Médecine Interne, Centre Hospitalier Universitaire, F-21000, Dijon, France.
Diane BouvryDépartement de Pneumologie, Hôpital Avicenne, AP-HP, Université Paris 13, F-93000, Bobigny, France.
Marc AndréDépartement de Médecine Interne, CHU Gabriel Montpied, F-63000, Clermont-Ferrand, France.
Nicolas NoëlDépartement de Médecine Interne et d'Immunologie Clinique, AP-HP, CHU Bicêtre, Université Paris Sud, UMR 1184, F-94270, Le Kremlin Bicêtre, France.
Boris BienvenuDépartement de Médecine Interne, Centre Hospitalier Universitaire, F-14033, Caen, France.
Alice ProuxDépartement de Médecine Interne de Gériatrie Thérapeutique, Hôpital Saint-Julien, CHU de Rouen, F-76031 Rouen Cedex, France.
Sandra VukusicUniversité Claude Bernard, Lyon 1, F-69100, Villeurbanne, France.
Bahram BodaghiDépartement d'Ophtalmologie, AP-HP, CHU Pitié Salpêtrière, F-75013, Paris, France.
Françoise Sarrot-ReynaudDépartement de Médecine Interne, Centre Hospitalier Universitaire, F-38700, Grenoble, France.
Jean IwazService de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France.
Christiane BroussolleDépartement de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, F-69004, Lyon, France.
David SaadounDépartement de Médecine Interne et d'Immunologie Clinique II, Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Pitié Salpêtrière, Université Pierre et Marie Curie (UPMC), F-75006, Paris, France.
Yvan JamillouxDépartement de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, F-69004, Lyon, France.
Dominique ValeyreDépartement de Pneumologie, Hôpital Avicenne, AP-HP, Université Paris 13, F-93000, Bobigny, France.
Pascal SèveDépartement de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, F-69004, Lyon, France.
Groupe Sarcoïdose Francophone
Hospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

efficacysafetysarcoidosisTNF antagonistsuveitis

Identifiers

PMID32476825
PMCPMC7170113
OpenAlexW2610467995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.